LDE225 for Patients With PTCH1 or SMO Mutated Tumors
Clinical trial NCT02002689 · TERMINATED
Trial details
- NCT number
- NCT02002689
- Sponsor
- Novartis Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2014-02-01
- Primary completion
- 2015-03-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.